伝染性ファブリキウス嚢病ワクチンのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Infectious Bursal Disease Vaccine Market Insights and Forecast to 2027

• レポートコード：QY2112C03867 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は伝染性ファブリキウス嚢病ワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。伝染性ファブリキウス嚢病ワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ライブ、非アクティブ化）、用途別市場規模（動物薬局、オンライン販売、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・伝染性ファブリキウス嚢病ワクチンの世界市場概要 ・メーカー別の競争状況、市場シェア ・伝染性ファブリキウス嚢病ワクチンの種類別市場規模：ライブ、非アクティブ化 ・伝染性ファブリキウス嚢病ワクチンの用途別市場規模：動物薬局、オンライン販売、その他 ・北米の伝染性ファブリキウス嚢病ワクチン市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの伝染性ファブリキウス嚢病ワクチン市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの伝染性ファブリキウス嚢病ワクチン市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の伝染性ファブリキウス嚢病ワクチン市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの伝染性ファブリキウス嚢病ワクチン市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Zoetis、Merck、Elanco、Boehringer Ingelheim、Ceva、Qingdao Yibang Biological Engineering Co., Ltd.、Shandong Lvdu Biological Technology Co., Ltd.、Plyco Bioengineering Co., Ltd.、Ruipu Biopharmaceutical Co., Ltd.、Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. ・伝染性ファブリキウス嚢病ワクチンのバリューチェーン・販売チャネル分析 ・伝染性ファブリキウス嚢病ワクチンの世界市場動向

Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.

Market Analysis and Insights: Global Infectious Bursal Disease Vaccine Market
The global Infectious Bursal Disease Vaccine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Infectious Bursal Disease Vaccine Scope and Segment
Infectious Bursal Disease Vaccine market is segmented by Type, and by Distribution Channel. Players, stakeholders, and other participants in the global Infectious Bursal Disease Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2016-2027.

Segment by Type
Live
Inactivated

Segment by Distribution Channel
Veterinary Pharmacy
Online Sale
Others

By Company
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Infectious Bursal Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Type
1.2.2 Live
1.2.3 Inactivated
1.3 Market by Distribution Channel
1.3.1 Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Distribution Channel
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Infectious Bursal Disease Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Infectious Bursal Disease Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Infectious Bursal Disease Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Infectious Bursal Disease Vaccine Regions by Sales
2.4.1 Global Top Infectious Bursal Disease Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Infectious Bursal Disease Vaccine Regions by Sales (2022-2027)
2.5 Global Top Infectious Bursal Disease Vaccine Regions by Revenue
2.5.1 Global Top Infectious Bursal Disease Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Infectious Bursal Disease Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Infectious Bursal Disease Vaccine Sales by Manufacturers
3.1.1 Global Top Infectious Bursal Disease Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Infectious Bursal Disease Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Infectious Bursal Disease Vaccine Sales in 2020
3.2 Global Infectious Bursal Disease Vaccine Revenue by Manufacturers
3.2.1 Global Top Infectious Bursal Disease Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Infectious Bursal Disease Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Bursal Disease Vaccine Revenue in 2020
3.3 Global Infectious Bursal Disease Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infectious Bursal Disease Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Infectious Bursal Disease Vaccine Sales by Type
4.1.1 Global Infectious Bursal Disease Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Infectious Bursal Disease Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Infectious Bursal Disease Vaccine Revenue by Type
4.2.1 Global Infectious Bursal Disease Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Infectious Bursal Disease Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Infectious Bursal Disease Vaccine Price by Type
4.3.1 Global Infectious Bursal Disease Vaccine Price by Type (2016-2021)
4.3.2 Global Infectious Bursal Disease Vaccine Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Infectious Bursal Disease Vaccine Sales by Distribution Channel
5.1.1 Global Infectious Bursal Disease Vaccine Historical Sales by Distribution Channel (2016-2021)
5.1.2 Global Infectious Bursal Disease Vaccine Forecasted Sales by Distribution Channel (2022-2027)
5.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2027)
5.2 Global Infectious Bursal Disease Vaccine Revenue by Distribution Channel
5.2.1 Global Infectious Bursal Disease Vaccine Historical Revenue by Distribution Channel (2016-2021)
5.2.2 Global Infectious Bursal Disease Vaccine Forecasted Revenue by Distribution Channel (2022-2027)
5.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2027)
5.3 Global Infectious Bursal Disease Vaccine Price by Distribution Channel
5.3.1 Global Infectious Bursal Disease Vaccine Price by Distribution Channel (2016-2021)
5.3.2 Global Infectious Bursal Disease Vaccine Price Forecast by Distribution Channel (2022-2027)

6 North America
6.1 North America Infectious Bursal Disease Vaccine Market Size by Type
6.1.1 North America Infectious Bursal Disease Vaccine Sales by Type (2016-2027)
6.1.2 North America Infectious Bursal Disease Vaccine Revenue by Type (2016-2027)
6.2 North America Infectious Bursal Disease Vaccine Market Size by Distribution Channel
6.2.1 North America Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2027)
6.2.2 North America Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2027)
6.3 North America Infectious Bursal Disease Vaccine Market Size by Country
6.3.1 North America Infectious Bursal Disease Vaccine Sales by Country (2016-2027)
6.3.2 North America Infectious Bursal Disease Vaccine Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Infectious Bursal Disease Vaccine Market Size by Type
7.1.1 Europe Infectious Bursal Disease Vaccine Sales by Type (2016-2027)
7.1.2 Europe Infectious Bursal Disease Vaccine Revenue by Type (2016-2027)
7.2 Europe Infectious Bursal Disease Vaccine Market Size by Distribution Channel
7.2.1 Europe Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2027)
7.2.2 Europe Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2027)
7.3 Europe Infectious Bursal Disease Vaccine Market Size by Country
7.3.1 Europe Infectious Bursal Disease Vaccine Sales by Country (2016-2027)
7.3.2 Europe Infectious Bursal Disease Vaccine Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Type
8.1.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Type (2016-2027)
8.1.2 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Type (2016-2027)
8.2 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Distribution Channel
8.2.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2027)
8.2.2 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2027)
8.3 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Region
8.3.1 Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2016-2027)
8.3.2 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Infectious Bursal Disease Vaccine Market Size by Type
9.1.1 Latin America Infectious Bursal Disease Vaccine Sales by Type (2016-2027)
9.1.2 Latin America Infectious Bursal Disease Vaccine Revenue by Type (2016-2027)
9.2 Latin America Infectious Bursal Disease Vaccine Market Size by Distribution Channel
9.2.1 Latin America Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2027)
9.2.2 Latin America Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2027)
9.3 Latin America Infectious Bursal Disease Vaccine Market Size by Country
9.3.1 Latin America Infectious Bursal Disease Vaccine Sales by Country (2016-2027)
9.3.2 Latin America Infectious Bursal Disease Vaccine Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Type
10.1.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Type (2016-2027)
10.1.2 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Type (2016-2027)
10.2 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Distribution Channel
10.2.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2027)
10.2.2 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2027)
10.3 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Country
10.3.1 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2016-2027)
10.3.2 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Zoetis Infectious Bursal Disease Vaccine Product Description
11.1.5 Zoetis Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Merck Infectious Bursal Disease Vaccine Product Description
11.2.5 Merck Recent Developments
11.3 Elanco
11.3.1 Elanco Corporation Information
11.3.2 Elanco Overview
11.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Elanco Infectious Bursal Disease Vaccine Product Description
11.3.5 Elanco Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Description
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Ceva
11.5.1 Ceva Corporation Information
11.5.2 Ceva Overview
11.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Ceva Infectious Bursal Disease Vaccine Product Description
11.5.5 Ceva Recent Developments
11.6 Qingdao Yibang Biological Engineering Co., Ltd.
11.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
11.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Overview
11.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Description
11.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
11.7 Shandong Lvdu Biological Technology Co., Ltd.
11.7.1 Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
11.7.2 Shandong Lvdu Biological Technology Co., Ltd. Overview
11.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Description
11.7.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
11.8 Plyco Bioengineering Co., Ltd.
11.8.1 Plyco Bioengineering Co., Ltd. Corporation Information
11.8.2 Plyco Bioengineering Co., Ltd. Overview
11.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Description
11.8.5 Plyco Bioengineering Co., Ltd. Recent Developments
11.9 Ruipu Biopharmaceutical Co., Ltd.
11.9.1 Ruipu Biopharmaceutical Co., Ltd. Corporation Information
11.9.2 Ruipu Biopharmaceutical Co., Ltd. Overview
11.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Description
11.9.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
11.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
11.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
11.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Overview
11.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Description
11.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Infectious Bursal Disease Vaccine Value Chain Analysis
12.2 Infectious Bursal Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infectious Bursal Disease Vaccine Production Mode & Process
12.4 Infectious Bursal Disease Vaccine Sales and Marketing
12.4.1 Infectious Bursal Disease Vaccine Sales Channels
12.4.2 Infectious Bursal Disease Vaccine Distributors
12.5 Infectious Bursal Disease Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infectious Bursal Disease Vaccine Industry Trends
13.2 Infectious Bursal Disease Vaccine Market Drivers
13.3 Infectious Bursal Disease Vaccine Market Challenges
13.4 Infectious Bursal Disease Vaccine Market Restraints

14 Key Findings in The Global Infectious Bursal Disease Vaccine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Live
Table 3. Major Manufacturers of Inactivated
Table 4. Global Infectious Bursal Disease Vaccine Market Size Growth Rate by Distribution Channel, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Infectious Bursal Disease Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Infectious Bursal Disease Vaccine Sales by Region (2016-2021) & (K Units)
Table 7. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2016-2021)
Table 8. Global Infectious Bursal Disease Vaccine Sales by Region (2022-2027) & (K Units)
Table 9. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2022-2027)
Table 10. Global Infectious Bursal Disease Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2016-2021)
Table 12. Global Infectious Bursal Disease Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2022-2027)
Table 14. Global Infectious Bursal Disease Vaccine Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Infectious Bursal Disease Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Global Infectious Bursal Disease Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Infectious Bursal Disease Vaccine Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Infectious Bursal Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Infectious Bursal Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Bursal Disease Vaccine as of 2020)
Table 21. Infectious Bursal Disease Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Infectious Bursal Disease Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Infectious Bursal Disease Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 26. Global Infectious Bursal Disease Vaccine Sales by Type (2022-2027) & (K Units)
Table 27. Global Infectious Bursal Disease Vaccine Sales Share by Type (2016-2021)
Table 28. Global Infectious Bursal Disease Vaccine Sales Share by Type (2022-2027)
Table 29. Global Infectious Bursal Disease Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Infectious Bursal Disease Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Infectious Bursal Disease Vaccine Revenue Share by Type (2016-2021)
Table 32. Global Infectious Bursal Disease Vaccine Revenue Share by Type (2022-2027)
Table 33. Infectious Bursal Disease Vaccine Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Infectious Bursal Disease Vaccine Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 36. Global Infectious Bursal Disease Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 37. Global Infectious Bursal Disease Vaccine Sales Share by Distribution Channel (2016-2021)
Table 38. Global Infectious Bursal Disease Vaccine Sales Share by Distribution Channel (2022-2027)
Table 39. Global Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 40. Global Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 41. Global Infectious Bursal Disease Vaccine Revenue Share by Distribution Channel (2016-2021)
Table 42. Global Infectious Bursal Disease Vaccine Revenue Share by Distribution Channel (2022-2027)
Table 43. Infectious Bursal Disease Vaccine Price by Distribution Channel (2016-2021) & (US$/Unit)
Table 44. Global Infectious Bursal Disease Vaccine Price Forecast by Distribution Channel (2022-2027) & (US$/Unit)
Table 45. North America Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 46. North America Infectious Bursal Disease Vaccine Sales by Type (2022-2027) & (K Units)
Table 47. North America Infectious Bursal Disease Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Infectious Bursal Disease Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 50. North America Infectious Bursal Disease Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 51. North America Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 52. North America Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 53. North America Infectious Bursal Disease Vaccine Sales by Country (2016-2021) & (K Units)
Table 54. North America Infectious Bursal Disease Vaccine Sales by Country (2022-2027) & (K Units)
Table 55. North America Infectious Bursal Disease Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Infectious Bursal Disease Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 58. Europe Infectious Bursal Disease Vaccine Sales by Type (2022-2027) & (K Units)
Table 59. Europe Infectious Bursal Disease Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Infectious Bursal Disease Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 62. Europe Infectious Bursal Disease Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 63. Europe Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 64. Europe Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 65. Europe Infectious Bursal Disease Vaccine Sales by Country (2016-2021) & (K Units)
Table 66. Europe Infectious Bursal Disease Vaccine Sales by Country (2022-2027) & (K Units)
Table 67. Europe Infectious Bursal Disease Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Infectious Bursal Disease Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Infectious Bursal Disease Vaccine Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 74. Asia Pacific Infectious Bursal Disease Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 75. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 76. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 77. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Infectious Bursal Disease Vaccine Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Infectious Bursal Disease Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Infectious Bursal Disease Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 86. Latin America Infectious Bursal Disease Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 87. Latin America Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 88. Latin America Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 89. Latin America Infectious Bursal Disease Vaccine Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Infectious Bursal Disease Vaccine Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Infectious Bursal Disease Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Infectious Bursal Disease Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 98. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 99. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Major Businesses
Table 107. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Zoetis Infectious Bursal Disease Vaccine Product
Table 109. Zoetis Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Merck Infectious Bursal Disease Vaccine Product
Table 114. Merck Recent Developments
Table 115. Elanco Corporation Information
Table 116. Elanco Description and Major Businesses
Table 117. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Elanco Infectious Bursal Disease Vaccine Product
Table 119. Elanco Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Ceva Corporation Information
Table 126. Ceva Description and Major Businesses
Table 127. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Ceva Infectious Bursal Disease Vaccine Product
Table 129. Ceva Recent Developments
Table 130. Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
Table 131. Qingdao Yibang Biological Engineering Co., Ltd. Description and Major Businesses
Table 132. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 134. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
Table 135. Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
Table 136. Shandong Lvdu Biological Technology Co., Ltd. Description and Major Businesses
Table 137. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 139. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
Table 140. Plyco Bioengineering Co., Ltd. Corporation Information
Table 141. Plyco Bioengineering Co., Ltd. Description and Major Businesses
Table 142. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 144. Plyco Bioengineering Co., Ltd. Recent Developments
Table 145. Ruipu Biopharmaceutical Co., Ltd. Corporation Information
Table 146. Ruipu Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 147. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 149. Ruipu Biopharmaceutical Co., Ltd. Recent Developments
Table 150. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
Table 151. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Major Businesses
Table 152. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 154. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Infectious Bursal Disease Vaccine Distributors List
Table 158. Infectious Bursal Disease Vaccine Customers List
Table 159. Infectious Bursal Disease Vaccine Market Trends
Table 160. Infectious Bursal Disease Vaccine Market Drivers
Table 161. Infectious Bursal Disease Vaccine Market Challenges
Table 162. Infectious Bursal Disease Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Infectious Bursal Disease Vaccine Product Picture
Figure 2. Global Infectious Bursal Disease Vaccine Market Share by Type in 2020 & 2027
Figure 3. Live Product Picture
Figure 4. Inactivated Product Picture
Figure 5. Global Infectious Bursal Disease Vaccine Market Share by Distribution Channel in 2020 & 2027
Figure 6. Veterinary Pharmacy
Figure 7. Online Sale
Figure 8. Others
Figure 9. Infectious Bursal Disease Vaccine Report Years Considered
Figure 10. Global Infectious Bursal Disease Vaccine Sales 2016-2027 (K Units)
Figure 11. Global Infectious Bursal Disease Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Infectious Bursal Disease Vaccine Revenue 2016-2027 (US$ Million)
Figure 13. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2022-2027)
Figure 16. North America Infectious Bursal Disease Vaccine Sales YoY (2016-2027) & (K Units)
Figure 17. North America Infectious Bursal Disease Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Infectious Bursal Disease Vaccine Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Infectious Bursal Disease Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Infectious Bursal Disease Vaccine Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Infectious Bursal Disease Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Infectious Bursal Disease Vaccine Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Infectious Bursal Disease Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Infectious Bursal Disease Vaccine Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Infectious Bursal Disease Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Infectious Bursal Disease Vaccine Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Infectious Bursal Disease Vaccine Revenue in 2020
Figure 28. Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2027)
Figure 30. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2027)
Figure 31. Global Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 32. Global Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 33. North America Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2027)
Figure 34. North America Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2027)
Figure 35. North America Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 36. North America Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 37. North America Infectious Bursal Disease Vaccine Sales Share by Country (2016-2027)
Figure 38. North America Infectious Bursal Disease Vaccine Revenue Share by Country (2016-2027)
Figure 39. United States Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2027)
Figure 42. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2027)
Figure 43. Europe Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 44. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 45. Europe Infectious Bursal Disease Vaccine Sales Share by Country (2016-2027)
Figure 46. Europe Infectious Bursal Disease Vaccine Revenue Share by Country (2016-2027)
Figure 47. Germany Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 48. France Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 55. Asia Pacific Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 56. Asia Pacific Infectious Bursal Disease Vaccine Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Infectious Bursal Disease Vaccine Revenue Share by Region (2016-2027)
Figure 58. China Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. India Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2027)
Figure 68. Latin America Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 70. Latin America Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 71. Latin America Infectious Bursal Disease Vaccine Sales Share by Country (2016-2027)
Figure 72. Latin America Infectious Bursal Disease Vaccine Revenue Share by Country (2016-2027)
Figure 73. Mexico Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 80. Middle East and Africa Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 81. Middle East and Africa Infectious Bursal Disease Vaccine Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Infectious Bursal Disease Vaccine Revenue Share by Country (2016-2027)
Figure 83. Turkey Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Infectious Bursal Disease Vaccine Revenue (2016-2027) & (US$ Million)
Figure 86. Infectious Bursal Disease Vaccine Value Chain
Figure 87. Infectious Bursal Disease Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---